(Reuters) -The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the ...

This is read by an automated voice. Please report any issues or inconsistencies here. There are more than 100 autoimmune diseases, affecting tens of millions as cases continue to rise, and 4 in 5 ...

PHOENIX — Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth ...

Psoriasis is well known for causing too many skin cells on elbows, knees and across the body, but people living with psoriasis may also be at an increased risk of heart disease. Effects of overactive ...

Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection ...

Add Yahoo as a preferred source to see more of our stories on Google. Jan 5 (Reuters) - Zenas BioPharma said on Monday its experimental drug cut the risk of disease flare-ups in a late-stage study of ...